Next Article in Journal
Stability of Executive Functioning of Moderately-Late Preterm and Full-Term Born Children at Ages 11 and 19: The TRAILS Cohort Study
Previous Article in Journal
Outdoor Playground Design Criteria Development for Early Childhood Development: A Delphi Study from the Perspective of Fundamental Movement Skills and Perceptual-Motor Skills
 
 
Correction published on 12 May 2023, see Int. J. Environ. Res. Public Health 2023, 20(10), 5809.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Intention for Screening Colonoscopy among Previous Non-Participants: Results of a Representative Cross-Sectional Study in Germany

1
Robert Koch Institute, Department of Epidemiology and Health Monitoring, General-Pape-Str. 62-66, 12101 Berlin, Germany
2
Institute for Public Health, Charité–Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2021, 18(8), 4160; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18084160
Submission received: 3 March 2021 / Revised: 11 April 2021 / Accepted: 13 April 2021 / Published: 14 April 2021 / Corrected: 12 May 2023
(This article belongs to the Section Health Behavior, Chronic Disease and Health Promotion)

Abstract

:
Early detection of colorectal cancer has the potential to reduce mortality at population level. Colonoscopy is the preferred modality for colon cancer screening and prevention, but attendance rates are low. To exploit colonoscopy’s preventive potential, it is necessary to identify the factors influencing uptake, especially among previous non-participants. This analysis of cross-sectional data involved 936 non-participants in screening colonoscopy aged 55 years or older in Germany. Differences between non-participants with and without future participation intentions were investigated in terms of socio-demographic factors, health status, attitudes and beliefs, and medical counselling. Logistic regression models were fitted to estimate associations between intention to participate and selected factors. Intention to participate was lower among women than among men. For both genders, intention to participate was positively associated with younger age. For women, higher socioeconomic status and counselling were positively associated with intention to participate. Men showed a positive association with favouring joint decision-making. The results draw attention to starting points for improving acceptance of and participation in screening colonoscopy. This includes good medical counselling and successful physician–patient communication, for which the information and communication skills of both medical professions and the general public should be strengthened. Gender differences should be considered.

1. Introduction

Colorectal cancer (CRC) is currently one of the three most common cancers in Germany. In 2016, about 25,990 women and 32,300 men were diagnosed with CRC [1]. This means that 1 in 20 women and 1 in 17 men will be diagnosed with the disease in the course of their lives. In Germany, mortality rates of patients with CRC have decreased significantly over the last decade. Nevertheless, 11,391 women and 13,411 men died with this diagnosis in 2016 [1]. Early detection and treatment of CRC are interventions that have been shown to reduce mortality at population level [2,3,4,5]. Colonoscopy is the preferred modality for both colon cancer screening and colon cancer prevention, because during colonoscopy the colon is examined for potentially cancerous tissue, as well as proliferation of the intestinal mucosa (intestinal polyps) which can usually be removed during the examination. The patient’s prognosis for CRC depends in particular on the stage of the tumour, with better outcomes associated with earlier stages. Within 10 years after the introduction of screening colonoscopy in Germany, the incidence of colorectal cancer has decreased in the age groups 55 and older, which is considered a success of screening colonoscopy [3]. In Germany, CRC screening (CRCS) is regulated by law, and the costs of these examinations are covered by all statutory health insurers, which insure approximately 86% of the population. Individual participation in CRCs is optional. In Germany, two examination methods are used: insured persons aged 50 years and older can choose between faecal occult blood testing (FOBT) and screening colonoscopy. The tests are offered at scheduled intervals depending on age and gender, and there is a choice between the two alternatives [6]. If the result of the FOBT is positive, this test is followed by diagnostic colonoscopy. Since there are screening options, medical counselling is provided by all physicians who perform CRCS examinations. As part of this counselling, the following aspects should be explained: frequency and disease pattern of CRC; the goal and concept of screening examinations; the examinations’ sensitivity, specificity, efficiency (reducing mortality from CRC) and possible disadvantages (burdens and medical risks); and the way forward in case of a positive finding [7].
Data from the statutory health insurance system show that CRCS uptake rates are low in Germany. For example, the uptake of FOBT was 19.8% of eligible women and 15.7% of eligible men from 2017 to 2018. The cumulative uptake of screening colonoscopy from 2009 to 2018 was 15.1% among eligible women and 13.8% among eligible men [8]. Low uptake rates for FOBT and colonoscopy have also been reported in other European countries [9,10].
Screening colonoscopy offers the potential for both primary and secondary prevention. To exploit this preventive potential, it is necessary to identify the factors that influence uptake, especially among those who have not yet participated. Socio-demographic factors, especially age, gender and social status [11,12,13]; indicators of health [14]; and aspects of physician–patient communication, especially physician recommendation, are considered to influence participation [15,16,17]. Attitudes and beliefs—both decision-making preferences in general and those that are specific to the use of a screening examination (e.g., whether shared decision-making is favoured)—are also assumed to have an impact [18,19,20]. In addition, access to the healthcare system and the reimbursement of examination costs may also be important [21]. However, most of studies on this topic have been conducted in the United States, Great Britain or the Netherlands and, therefore, cannot be easily transferred to the German healthcare system context or the doctor-patient situation in Germany.
Non-participants in CRCS and their intentions to have a colonoscopy for CRCS have not yet been investigated in a representative study in Germany. Data are also lacking on the association of socio-demographic factors, health status, health-related attitudes and beliefs, and medical counselling with intention to have a colonoscopy.
The aim of the present study was therefore to examine the following research questions:
  • Among the group of previous non-participants in CRCS, do those who intend to have a screening colonoscopy differ from those who do not?
  • What are the determinants of intention to have a screening colonoscopy among non-participants?
  • Is intention to have a screening colonoscopy associated with physician counselling?

2. Materials and Methods

2.1. Study Design and Study Population

The present analyses are based on data from the study ‘KomPaS: Survey on Communication and Patient Safety’, a representative cross-sectional telephone survey of the German-speaking residential population aged 18 years and over living in a private household in Germany, conducted by the Robert Koch Institute. In the survey period (May–September 2017), a total of 5053 people were interviewed. The sample was drawn using the dual-frame method (ratio of 60% landline numbers to 40% mobile numbers) from the ADM Telephone Survey System provided by the ADM Arbeitskreis Deutscher Markt- und Sozialforschungsinstitute e.V. (ADM Working Group of German Market and Social Research Institutes). The response rate according to criteria of the American Association for Public Opinion Research (AAPOR Outcome Rate Calculator; Dual-Frame RDD phone; Version 4.0, May, 2016) was 17.2%. The aim of the study was to describe different areas of information behaviour, decision-making behaviour and communication behaviour of patients, as well as the physician–patient relationship, from a population perspective. The questionnaire developed for the KomPaS study was tested by a qualitative and quantitative pre-test. For the qualitative testing of the questionnaire, we cooperated with an external research institute specialized in questionnaire testing. The detailed study procedure and methodology have been published elsewhere [22,23].
One part of the study focused on the early detection of CRC. For this purpose, 2901 people aged 55 years or older were interviewed because people of this age are entitled to a colonoscopy for the early detection of CRC [24]. The items used in the questionnaire were based on survey instruments that had previously been used in other studies [25,26,27,28]. The study participants were asked whether they had ever had a colonoscopy (answer options: yes, no). All individuals who provided a negative answer to this question were classified as previous non-participants—the study population of the present analyses (n = 936).

2.2. Indicators

Intention to participate in a screening colonoscopy, the outcome measure in this study, was assessed with the following question: ‘Do you intend to have a colonoscopy for early cancer detection in the future?’ (yes, no).
The following determinants were examined as independent variables: in addition to age and gender, information on education, occupational status and income was collected to determine socioeconomic status (SES; low, medium or high) [29].
Several questions were asked to assess different aspects of health: self-perceived health (‘How is your health in general? Is it very good, good, fair, bad or very bad?’); long-standing health problems (‘Do you have any longstanding illnesses or health problems?’ (yes, no) and limitations in activities because of health problems (‘Are you limited because of a health problem in activities people usually do? Would you say you are severely limited, limited but not severely or not limited at all?’).
Health awareness was assessed by asking ‘How strongly do you generally pay attention to your health?’ (very strong, strong, moderate, less strong, not at all), and health-related locus of control was assessed by asking ‘How much can you do yourself to maintain or improve your health?’ (nothing, little, some, much, very much). Treatment decision-making preferences were measured by asking ‘Which of the following statements would you most agree with? My doctor should keep me informed, but in general he should decide how best to treat me; My doctor should discuss the different treatment options with me, and we will then come to a joint decision; and My doctor should explain the different treatment options and the pros and cons, and then I will decide what to do’. We categorized the answers as ‘physician’s decision favoured’, ‘joint decision making favoured’ or ‘own decision making favoured’.
The study participants were asked to recall previously conducted physician counselling when responding to the following question: ‘Has a doctor ever advised you about colon cancer and the existing possibilities for early detection (e.g., stool test or colonoscopy)?’ (yes, no).

2.3. Statistical Analyses

The analyses used data from 936 people aged 55 years or older who had not yet had a colonoscopy. Relative frequencies and 95% confidence intervals (CIs) are reported. Wider CIs indicate greater statistical uncertainty in the results (Table 1).
Using Pearson’s χ2 test, differences between non-participants with and without the intention to participate in screening colonoscopy in the future were analysed for statistical significance with regard to the determinants described above. A significant group difference was assumed if the p-value calculated considering the weighting and the survey design was smaller than 0.05. Multivariate binary logistic regression was used to test for associations between intention to participate in screening colonoscopy in the future (the outcome variable) and the tested determinants. For this purpose, odds ratios (ORs) were calculated for intention to participate in screening colonoscopy in the future with 95% CIs and p-values. All analyses were conducted with Stata 15.1 [30] using survey procedures for complex samples, which allows weighting to be appropriately taken into account when calculating CIs and p-values. Weighting factors were used to correct for sample deviations from the population structure in terms of age, gender, education and place of residence (community type), referring to German Federal Statistical Office data for 2017 [23].

3. Results

3.1. Comparison of Non-Participants with and without Intention to Participate in Screening Colonoscopy in the Future

Group differences in socio-demographic factors, health status, attitudes and beliefs, and physician counselling were examined (Table 2). Significantly fewer women than men expressed an intention to participate in screening colonoscopy (p = 0.0001). Regarding the other examined socioeconomic factors, intention to participate in screening colonoscopy decreased significantly with age for both genders. Men with high SES expressed the lowest intention; among women, intention was lowest among those with low SES (differences not significant). For both men and women, there were no significant differences between individuals who intended to participate in screening colonoscopy and those who did not in terms of health status indicators. One attitude and belief determinant had a significant effect only among men: the lowest level of intention to participate in screening colonoscopy was expressed by those who favoured physician decision making. For physician counselling, intention to participate in screening colonoscopy varied significantly only among women, who had significantly lower levels of intention to participate if they had not received counselling than if they had received counselling.

3.2. Associations between Intention to Participate in Screening Colonoscopy and the Examined Determinants

Because of group differences, binary logistic regression was used to test the associations between the determinants and intention to participate in screening colonoscopy in the future (Table 3). In addition to the raw ORs, we present the ORs from a model that adjusted for respondent’s age and SES to examine the extent to which independent associations existed between intention to participate in screening colonoscopy and the examined determinants.
Men and women aged 55–59 years or aged 60–64 years had increased odds of intention to participate, compared with those aged 65 years or older. Women with medium or low SES had lower odds of intending to participate in screening colonoscopy compared with women with high SES. Men who favoured joint decision making had a significantly higher odds of intending to participate compared with those who favoured a physician’s decision. This effect increased after adjusting for age and SES. Among women, those who had received physician counselling had a significantly higher odds of intending to participate compared with those who had not received such counselling. Here, too, the effect intensified after adjustment, indicating a strong independent association.

4. Discussion

Summarised this is the first representative study on non-participants in CRCS and their intentions to have a colonoscopy for CRCS in future in Germany. We, first, generated data on the association of socio-demographic factors, health status, health-related attitudes and beliefs, and medical counselling with intention to have a colonoscopy. The main findings are: (1) The intention to participate is lower for women than for men and for both genders, intention to participate was positively associated with younger age; and (2) determinants of intention to have a screening colonoscopy among non-participants are for women higher socioeconomic status and counselling and for men favouring joint decision making.
Our results show age-related differences in the intention to participate in screening colonoscopy: people aged under 65 years express a higher level of intention to participate than do older individuals. This finding was also reported in a previous study [31]. The data on CRCS colonoscopy attendance in Germany show lower participation for the 55–59 years age group compared with older age groups [9,32]. Thus, previous non-participants aged under 65 years seem to intend to participate but probably in the distant future (i.e., at older ages). This finding may also be related to people realising that the probability of CRC increases with age; however, this understanding could also increase the fear of being diagnosed with CRC, which may reduce willingness to participate [33]. Furthermore, medical reasons that increase with age, maybe contrary to participation intentions such as a non-functioning bowel or a terminal illness [34]. We did not investigate these aspects in our study.
We found, that intention to participate in screening colonoscopy is associated with SES for women but not for men. This finding is in line with a previous report of little difference in men’s CRCS (FOBT and colonoscopy) attendance by SES [35]. The results for women are also consistent with previous studies indicating that women with higher SES are more likely to use preventive services [36] and have a higher level of intention to participate in CRCS [37]. The association between SES and intention to participate is explained by people with higher SES being better informed, having less fear of the examination and being more likely to consider cancer screening useful [38].
Attitude towards decision making is considered an influencing factor for participation in CRCS [20]; this idea is confirmed by the present results for men. A US study conducted by Messina et al. [20] showed that previous non-participation in CRCS was associated with a lower likelihood of involving a physician in CRCS decisions; however, the authors acknowledged that people who prefer to make screening decisions on their own are more likely to have negative rather than positive attitudes towards screening, compared with those with other decision-making preferences, and that attitudes towards screening are probably more important than a preference for a particular type of decision making. In our survey, treatment decision-making preferences were assessed in general terms not specific to CRCS, so the results are not directly comparable to previous work. Because of the different screening options for CRCS in Germany and the counselling provided for this reason, the association between the intention to participate and favouring a joint treatment decision is understandable. This finding is in line with the results of previous studies on the patient–doctor relationship in Germany, which show that joint decision making is favoured in general and in the context of early cancer detection [28,39]. Joint or shared decision making is positively associated with making informed decisions, including regarding cancer screening [40]. A decision is considered informed if it is based on sufficient knowledge about the advantages and disadvantages of the examination, in accordance with personal attitudes, which are then reflected in the decision for participation or non-participation [41].
In our results we found an association between intention to participate in screening colonoscopy and previous physician counselling, but only for women. A good physician–patient relationship is attributed to a positive influence on the course of disease and the success of treatment. A precondition for a good relationship is successful communication. Counselling, as a communication situation in the physician–patient relationship, is of major importance for the communication of health information. Despite the availability of health information from several sources, for most patients, the physician is the main point of contact for health-related questions [42]. Successful physician–patient communication depends on networking and co-operation between all parties involved [43]. Our findings are consistent with studies that have shown that the physician’s recommendation is a major contributing factor to whether CRCS examinations are taken up [39,44,45]. Studies on the content of physician–patient discussions on CRCS emphasize the importance of understanding which aspects of the discussion content facilitate an informed and value-compliant decision that could ultimately increase the uptake of CRCS [45,46]. We did not have information on the type or content of physician counselling in our study. Further research is needed in this area.
Our results indicate a difference in intention to participate in colonoscopy for CRCS between women and men, with more men than women expressing an intention to participate. A previous study also reported this result [47], but other studies have found no gender difference in intention to participate [48]. One explanation for the gender difference could be gender-specific barriers. In a qualitative study [49], women most frequently mentioned the intrusive examination method, the fear of perforation and embarrassment; for men, the most frequently cited reasons not to participate were avoiding the examination, not seeing any benefit in screening and the male role position being violated by the examination. Interestingly, there is little difference between women and men in Germany in the uptake of colonoscopy for the early detection of CRC [9,32], in contrast to the other statutory cancer screening examinations, which show a clear gender difference in favour of women [36]. The examined determinants also show gender-specific differences, supporting calls to make the offer of preventive services more gender sensitive. Furthermore, these findings make clear the necessity of adapting CRCS information and offers to the specific needs of women and men, especially considering their different morbidity and mortality rates [50,51].
The findings of our study draw attention to starting points for improving acceptance of and participation in screening colonoscopy, which are, however, associated with various challenges. Physicians must integrate counselling time into their daily medical routines, but there is a lack of incentives to do this in Germany because of low reimbursement [52]. Physicians are also responsible for providing counselling to women and men of different ages with different risk profiles, different levels of knowledge regarding cancer screening and different attitudes towards cancer screening and treatment decisions. Physicians need to be aware of these differences and tailor their efforts to the needs of their patients [53]. In their role as counsellors, doctors should develop their communication skills, and they need evidence-based and quality-assured information for their counselling. Additionally, medical students should already be prepared for later communication with patients during their studies. This has begun to be implemented in Germany [54]. However, not only those in the medical professions, but also the general population should be strengthened with regard to their information and communication competence. In Germany, attempts are being made to strengthen these aspects through specific measures to promote health literacy (e.g., through the Alliance of Central Actors in Health Care and the National Health Literacy Action Plan [55] as well as the National Cancer Plan [56]), with the aim of promoting both personal and organisational health literacy [57]. In Germany, there has been a health policy reorientation of early cancer detection since the beginning of the first decade of the 21st century, including the introduction of new legal regulations [58]. In accordance with European recommendations [59], an organised and quality-assured screening programme with an invitation and information system has been implemented in Germany since 2018 [6].
The KomPaS study was a snapshot in the time before the start of the organised and quality-assured screening programme. In order to evaluate the resulting possible improvement in the acceptance of colorectal cancer screening, a study on the intention to participate could be conducted again at a certain time interval. For future studies on this topic, we also propose to consider psychological factors such as fear of the complications of colonoscopy. In this way, existing gaps in the provision of information and in medical counselling could be identified.
The present study has several limitations that should be taken into account when generalising the results. Some limitations result from only certain determinants of intention to participate in screening colonoscopy being measured. Respondents may also remember the corresponding answer categories inaccurately (recall bias) or give socially desirable answers (social desirability bias), especially for intention to participate. Additionally, we did not have information on whether the participants had previously undergone FOBT for CRCS, their motivation for this type of examination or whether they reject cancer screening in general. We also did not have any information about the type or content of physician counselling, so we could not assess whether the benefits and risks of screening colonoscopy were explained in accordance with the guidelines or whether the doctors actively recommend the examination. Because of the study’s cross-sectional design, it was not possible form conclusions about the causality of the results. It is also known that telephone interviews are more susceptible to socially desirable response behaviour, compared with face-to-face interviews [60]. In addition, there is the possibility of bias caused by selective non-participation (selection bias). People who participate in a health survey can be assumed to have relatively high health awareness and therefore to differ from the general population in terms of non-participation in CRCS. Furthermore, certain population groups (e.g., individuals with a migration background or without sufficient knowledge of German) may be underrepresented in the sample because the interviews were conducted in German.
Possible selection effects were addressed by weighting, so the observed results are generalisable for Germany, which is a strength of the KomPaS study. In the present study, non-participants were examined using a representative population sample, and, because of the large sample size, we were able to conduct separate analyses for men and women. Our study is therefore a good supplement to analyses of statutory health insurance data and offers a starting point for the improvement and further development of CRCS.

5. Conclusions

The present study examined non-participants and their intention to participate in screening colonoscopy in the future. A preference for joint decision making and having received of physician counselling were found to be relevant factors. These findings draw attention to several potential starting points for improving screening colonoscopy acceptance and attendance. Strengthening the information and communication skills for doctors as well as for the general population is an essential aspect of this. Personal invitations with detailed information about the benefits and possible risks of the examinations should make it easier for individuals to decide whether or not to take advantage of these offers. These changes may also support the formation of intentions to participate among previous non-participants, in the sense of enabling them to make an informed decision.
To reduce barriers to intention to participate, age- and gender-specific needs, as well as attitudes and beliefs, should be taken more into account. However, further knowledge is needed, for example, to better explain gender differences and to evaluate the content and quality of medical counselling.

Author Contributions

Conceptualization: A.S., S.J. and F.P.; formal analysis: A.S.; writing—original draft preparation: A.S.; writing—review and editing: A.S., S.J. and F.P.; supervision: S.J. and F.P. All authors have read and agreed to the published version of the manuscript.

Funding

The KomPaS study was funded by the Federal Ministry of Health and the Robert Koch Institute (Funding code: ZMVI1-2516FSB410).

Institutional Review Board Statement

The study ‘KomPaS: survey on communication and patient-safety’ was subject to strict compliance with the data protection provisions set out in the EU General Data Protection Regulation and the Federal Data Protection Act. The Federal Commissioner for Data Protection and Freedom of Information approved the study on 21 June 2017. The Commissioner had no data privacy concerns about the study being carried out in the manner that was planned.

Informed Consent Statement

The participants of the study were informed about the objectives and contents of the study as well as about data protection and gave their consent to participate in the study. Participation in the study was voluntary.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available because informed consent from study participants did not cover public deposition of data. However, the minimal data set underlying the findings is archived in the ‘Health Monitoring’ Research Data Centre at the Robert Koch Institute (RKI) and can be accessed by all interested researchers. On-site access to the data set is possible at the Secure Data Center of the RKI’s ’Health Monitoring’ Research Data Centre. Requests should be submitted to the ’Health Monitoring’ Research Data Centre, Robert Koch Institute, Berlin, Germany (e-mail: [email protected]).

Acknowledgments

We thank Jennifer Barrett from Edanz Group for editing a draft of this manuscript.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Robert Koch-Institut (Hrsg) und die Gesellschaft der Epidemiologischen Krebsregister in Deutschland e.V. (Hrsg). Krebs in Deutschland für 2015/2016. 12. Ausgabe; Robert Koch Institut: Berlin, Germany, 2019.
  2. Altenhofen, L. Projekt Wissenschaftliche Begleitung von Früherkennungs-Koloskopien in Deutschland. Berichtszeitraum 2014. 12. Jahresbericht, Version 2 im Auftrag des GKV-Spitzenverbands und der Kassenärztlichen Bundesvereinigung; Zentralinstitut für die kassenärztliche Versorgung in Deutschland, Ed.; Zentralinstitut für die kassenärztliche Versorgung in Deutschland: Köln, Germany, 2016; pp. 15–21. [Google Scholar]
  3. Brenner, H.; Schrotz-King, P.; Holleczek, B.; Katalinic, A.; Hoffmeister, M. Rückgang der Inzidenz und Mortalität von Darmkrebs in Deutschland. Analyse zeitlicher Trends in den ersten 10 Jahren nach Einführung der Vorsorgekoloskopie [Declining bowel cancer incidence and mortality in Germany—An analysis of time trends in the first ten years after the introduction of screening colonoscopy]. Dtsch. Arztebl. Int. 2016, 113, 101–106. [Google Scholar] [CrossRef]
  4. Geurts, S.M.E.; Massat, N.J.; Duffy, S.W. Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: Impact on colorectal cancer cases and deaths. Br. J. Cancer 2015, 113, 142–149. [Google Scholar] [CrossRef]
  5. Zhang, J.; Cheng, Z.; Ma, Y.; He, C.; Lu, Y.; Zhao, Y.; Chang, X.; Zhang, Y.; Bai, Y.; Cheng, N. Effectiveness of screening modalities in colorectal cancer: A network meta-analysis. Clin. Colorectal Cancer 2017, 16, 252–263. [Google Scholar] [CrossRef] [PubMed]
  6. Gemeinsamer Bundesausschuss. Richtlinie des Gemeinsamen Bundesausschusses für Organisierte Krebsfrüherkennungsprogramme in der Version vom 05.12.2019. (Richtlinie für organisierte Krebsfrüherkennungsprogramme-oKFE-RL). Available online: https://www.g-ba.de/downloads/62-492-2001/oKFE-RL-2019-12-05-iK-2020-01-01.pdf (accessed on 19 October 2020).
  7. Gemeinsamer Bundesausschuss. Richtlinie des Gemeinsamen Bundesausschusses über die Früherkennung von Krebserkrankungen (Krebsfrüherkennungs-Richtlinie/KFE-RL) in der Version vom 18.01.2018. Available online: https://www.g-ba.de/downloads/62-492-1728/KFE-RL_2018-01-18_iK-2019-01-01.pdf (accessed on 19 October 2020).
  8. Central Research Institute of Ambulatory Health Care in Germany. Utilization of Statutory Measures for Early Detection (Faecal Occult Blood Test (FOBT), Coloscopy) and of Consultations for the Prevention of Colorectal Cancer. Available online: http://www.gbe-bund.de (accessed on 19 October 2020).
  9. Starker, A.; Buttmann-Schweiger, N.; Krause, L.; Barnes, B.; Kraywinkel, K.; Holmberg, C. Krebsfrüherkennungsuntersuchungen in Deutschland: Angebot und Inanspruchnahme [Cancer screening in Germany: Availability and participation]. Bundesgesundheitsblatt-Gesundh.-Gesundh. 2018, 61, 1491–1499. [Google Scholar] [CrossRef] [PubMed]
  10. Eurostat. Self-Reported Last Colorectal Cancer Screening Test by Sex, Age and Educational Attainment Level. Available online: https://ec.europa.eu/eurostat/databrowser/product/view/HLTH_EHIS_PA5E?lang=en (accessed on 18 September 2020).
  11. Sieverding, M.; Matterne, U.; Ciccarello, L.; Haug, U. Colonoscopy use in a country with a long-standing colorectal cancer screening programme: Evidence from a large German survey. Z. Gastroenterol. 2010, 48, 1351–1357. [Google Scholar] [CrossRef] [PubMed]
  12. Holden, D.J.; Jonas, D.E.; Porterfield, D.S.; Reuland, D.; Harris, R. Systematic review: Enhancing the use and quality of colorectal cancer screening. Ann. Intern. Med. 2010, 152, 668–676. [Google Scholar] [CrossRef] [PubMed]
  13. Scheffer, S.; Dauven, S.; Sieverding, M. Soziodemografische Unterschiede in der Teilnahme an Krebsfrüherkennungsuntersuchungen (KFU) in Deutschland-Eine Übersicht [Sociodemographic differences in the participation in “Early Detection of Cancer Examinations” in Germany—A review]. Gesundheitswesen 2006, 68, 139–146. [Google Scholar] [CrossRef] [PubMed]
  14. Deshpande, A.D.; McQueen, A.; Coups, E.J. Different effects of multiple health status indicators on breast and colorectal cancer screening in a nationally representative US sample. Cancer Epidemiol. 2012, 36, 270–275. [Google Scholar] [CrossRef]
  15. Lewis, S.F.; Jensen, N.M. Screening sigmoidoscopy. Factors associated with utilization. J. Gen. Intern. Med. 1996, 11, 542–544. [Google Scholar] [CrossRef] [PubMed]
  16. Guerra, C.E.; Dominguez, F.; Shea, J.A. Literacy and knowledge, attitudes, and behavior about colorectal cancer screening. J. Health Commun. 2005, 10, 651–663. [Google Scholar] [CrossRef] [PubMed]
  17. Nápoles, A.M.; Santoyo-Olsson, J.; Stewart, A.L.; Olmstead, J.; Gregorich, S.E.; Farren, G.; Cabral, R.; Freudman, A.; Pérez-Stable, E.J. Physician counseling on colorectal cancer screening and receipt of screening among Latino patients. J. Gen. Intern. Med. 2015, 30, 483–489. [Google Scholar] [CrossRef] [PubMed]
  18. Vernon, S.W. Participation in colorectal cancer screening: A review. J. Natl. Cancer Inst. 1997, 89, 1406–1422. [Google Scholar] [CrossRef] [PubMed]
  19. McQueen, A.; Vernon, S.W.; Rothman, A.J.; Norman, G.J.; Myers, R.E.; Tilley, B.C. Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior. Ann. Behav. Med. 2010, 40, 205–217. [Google Scholar] [CrossRef] [PubMed]
  20. Messina, C.R.; Lane, D.S.; Grimson, R. Colorectal cancer screening attitudes and practices: Preferences for decision making. Am. J. Prev. Med. 2005, 28, 439–446. [Google Scholar] [CrossRef] [PubMed]
  21. Knight, J.R.; Kanotra, S.; Siameh, S.; Jones, J.; Thompson, B.; Thomas-Cox, S. Understanding barriers to colorectal cancer screening in Kentucky. Prev. Chronic Dis. 2015, 12, E95. [Google Scholar] [CrossRef] [PubMed]
  22. Schmich, P.; Lemcke, J.; Zeisler, M.L.; Müller, A. Ad hoc surveys at the Robert Koch Institute. J. Health Monit. 2018, 3, 75–86. [Google Scholar] [CrossRef]
  23. Horch, K.; Starker, A.; Jordan, S.; Kommunikation und Information im Gesundheitswesen aus Sicht der Bevölkerung. Patientensicherheit und Informierte Entscheidung (KomPaS). Sachbericht. Available online: https://www.bundesgesundheitsministerium.de/service/publikationen/praevention/details.html?bmg[pubid]=3327 (accessed on 27 January 2021).
  24. Gemeinsamer Bundesausschuss. Richtlinie über Die Früherkennung von Krebserkrankungen in der Version vom 16.12.2010. (Krebsfrüherkennungs-Richtlinie/KFE-RL). Available online: https://www.g-ba.de/downloads/62-492-510/RL_KFU_2010-12-16.pdf (accessed on 19 October 2020).
  25. Starker, A.; Bertz, J.; Saß, A.C. Inanspruchnahme von Krebsfrüherkennungsuntersuchungen. In Daten und Fakten: Ergebnisse der Studie „Gesundheit in Deutschland Aktuell 2010“ Beiträge zur Gesundheitsberichterstattung des Bundes; Robert Koch-Institut, Ed.; Robert Koch-Institut: Berlin, Germany, 2012; pp. 27–38. [Google Scholar]
  26. Robert Koch-Institut. Fragebogen zur Studie „Gesundheit in Deutschland aktuell“: GEDA 2014/2015-EHIS. J. Health Monit. 2017, 2, 105–135. [Google Scholar] [CrossRef]
  27. Jordan, S.; von der Lippe, E. Angebote der Prävention—Wer nimmt teil? GBE Kompakt 2012, 3, 1–8. [Google Scholar] [CrossRef]
  28. Braun, B.; Marstedt, G. Partizipative Entscheidungsfindung beim Arzt: Anspruch und Wirklichkeit. In Gesundheitsmonitor 2014. Bürgerorientierung im Gesundheitswesen. Kooperationsprojekt der Bertelsmann Stiftung und der BARMER GEK; Böcken, J., Braun, B., Meierjürgen, R., Eds.; Verlag Bertelsmann Stiftung: Gütersloh, Germany, 2014; pp. 107–131. [Google Scholar]
  29. Lampert, T.; Kroll, L.E.; Müters, S.; Stolzenberg, H. Messung des sozioökonomischen Status in der Studie “Gesundheit in Deutschland aktuell” (GEDA) [Measurement of the socioeconomic status within the German Health Update 2009 (GEDA)]. Bundesgesundheitsblatt-Gesundh.-Gesundh. 2013, 56, 131–143. [Google Scholar] [CrossRef] [PubMed]
  30. StataCorp LLC. Stata Survey Data Reference Manual, Release 15. Stata Press. Available online: https://www.stata.com/manuals/svy.pdf (accessed on 29 November 2018).
  31. Gimeno-García, A.Z.; Quintero, E.; Nicolás-Pérez, D.; Jiménez-Sosa, A. Public awareness of colorectal cancer and screening in a Spanish population. Public Health 2011, 125, 609–615. [Google Scholar] [CrossRef]
  32. Starker, A.; Buttmann-Schweiger, N.; Kraywinkel, K.; Kuhnnert, R. The utilization of colonoscopy in Germany. J. Health Monit. 2017, 2, 76–81. [Google Scholar] [CrossRef]
  33. Bradley, D.T.; Treanor, C.; McMullan, C.; Owen, T.; Graham, A.; Anderson, D. Reasons for non-participation in the Northern Ireland Bowel Cancer Screening Programme: A qualitative study. BMJ Open 2015, 5. [Google Scholar] [CrossRef]
  34. Mead, L.; Porteous, L.; Tait, M.; Stoker, R.; Payne, S.; Calvert, C.; Maxwell, D.; Katikireddi, S.V. The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes. J. Med. Screen. 2015, 22, 106–108. [Google Scholar] [CrossRef] [PubMed]
  35. Starker, A.; Saß, A.-C. Inanspruchnahme von Krebsfrüherkennungsuntersuchungen [Participation in cancer screening in Germany. Results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt-Gesundh.-Gesundh. 2013, 56, 858–867. [Google Scholar] [CrossRef] [PubMed]
  36. Kowalski, C.; Loss, J.; Kölsch, F.; Janssen, C. Utilization of prevention services by gender, age, socioeconomic status, and migration status in Germany: An overview and a systematic review. In Health Care Utilization in Germany. Theory, Methodology, and Results; Janssen, C., Swart, E., von Lengerke, T., Eds.; Springer: New York, NY, USA; Heidelberg, Germany; Dordrecht, The Netherlands; London, UK, 2014; pp. 293–320. [Google Scholar]
  37. Wardle, J.; McCaffery, K.; Nadel, M.; Atkin, W. Socioeconomic differences in cancer screening participation: Comparing cognitive and psychosocial explanations. Soc. Sci. Med. 2004, 59, 249–261. [Google Scholar] [CrossRef]
  38. Quaife, S.L.; Winstanley, K.; Robb, K.A.; Simon, A.E.; Ramirez, A.J.; Forbes, L.J.L.; Brain, K.E.; Gavin, A.; Wardle, J. Socioeconomic inequalities in attitudes towards cancer: An international cancer benchmarking partnership study. Eur. J. Cancer Prev. 2015, 24. [Google Scholar] [CrossRef]
  39. DIW Berlin/SOEP (Ed.) SOEP 2010—Pretestbericht zum Befragungsjahr 2010 (Welle 27) des Sozio-Oekonomischen Panels—Haushaltsbilanz “Konsum”, “Krebsszenarien” und Sonstige Innovationsmodule SOEP Survey Papers, No. 74. Available online: https://www.econstor.eu/handle/10419/61585 (accessed on 13 February 2021).
  40. Zolnierek, K.B.H.; Dimatteo, M.R. Physician communication and patient adherence to treatment: A meta-analysis. Med. Care 2009, 47, 826–834. [Google Scholar] [CrossRef]
  41. Marteau, T.M.; Dormandy, E.; Michie, S. A measure of informed choice. Health Expect. 2001, 4, 99–108. [Google Scholar] [CrossRef] [PubMed]
  42. Baumann, E.; Czerwinski, F. Erst mal Doktor Google fragen? Nuzung neuer Medien zur Information und zum Austausch über Gesundheitsinformationen. In Gesundheitsmonitor 2015. Bürgerorientierung im Gesundheitswesen. Kooperationsprojekt der Bertelsmann Stiftung und der BARMER GEK; Böcken, J., Braun, B., Meierjürgen, R., Eds.; Bertelsmann Stiftung: Gütersloh, Germany, 2015; pp. 57–79. [Google Scholar]
  43. Grimm, M.; Baumann, E. Mediale Kommunikation im Kontext von Krebserkrankungen. In Handbuch der Gesundheitskommunikation; Rossmann, C., Hastall, M.R., Eds.; Springer VS: Wiesbaden, Germany, 2019; pp. 555–566. [Google Scholar]
  44. Guerra, C.E.; Schwartz, J.S.; Armstrong, K.; Brown, J.S.; Halbert, C.H.; Shea, J.A. Barriers of and facilitators to physician recommendation of colorectal cancer screening. J. Gen. Intern. Med. 2007, 22, 1681–1688. [Google Scholar] [CrossRef] [PubMed]
  45. Peterson, E.B.; Ostroff, J.S.; DuHamel, K.N.; D’Agostino, T.A.; Hernandez, M.; Canzona, M.R.; Bylund, C.L. Impact of provider–patient communication on cancer screening adherence: A systematic review. Prev. Med. 2016, 93, 96–105. [Google Scholar] [CrossRef] [PubMed]
  46. Lafata, J.E.; Divine, G.; Moon, C.; Williams, L.K. Patient–physician colorectal cancer screening discussions and screening use. Am. J. Prev. Med. 2006, 31, 202–209. [Google Scholar] [CrossRef]
  47. Power, E.; Van Jaarsveld, C.H.M.; McCaffery, K.; Miles, A.; Atkin, W.; Wardle, J. Understanding intentions and action in colorectal cancer screening. Ann. Behav. Med. 2008, 35, 285–294. [Google Scholar] [CrossRef] [PubMed]
  48. McKinney, S.Y.; Palmer, R.C. The influence of gender on colorectal cancer knowledge, screening intention, perceived risk and worry among African Americans in South Florida. J. Community Health 2014, 39, 230–238. [Google Scholar] [CrossRef] [PubMed]
  49. Ritvo, P.; Myers, R.E.; Paszat, L.; Serenity, M.; Perez, D.F.; Rabeneck, L. Gender differences in attitudes impeding colorectal cancer screening. BMC Public Health 2013, 13, 500. [Google Scholar] [CrossRef] [PubMed]
  50. White, A.; Ironmonger, L.; Steele, R.J.C.; Ormiston-Smith, N.; Crawford, C.; Seims, A. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer 2018, 18, 906. [Google Scholar] [CrossRef] [PubMed]
  51. Friedemann-Sánchez, G.; Griffin, J.M.; Partin, M.R. Gender differences in colorectal cancer screening barriers and information needs. Health Expect. 2007, 10, 148–160. [Google Scholar] [CrossRef]
  52. Rothenfluh, F.; Schulz, P.J. Arzt-Patient-Kommunikation. In Handbuch der Gesundheitskommunikation; Rossmann, C., Hastall, M.R., Eds.; Springer VS: Wiesbaden, Germany, 2019; pp. 57–67. [Google Scholar]
  53. Bao, Y.; Fox, S.A.; Escarce, J.J. Socioeconomic and racial/ethnic differences in the discussion of cancer screening: “Between-” versus “within-” physician differences. Health Serv. Res. 2007, 42, 950–970. [Google Scholar] [CrossRef] [PubMed]
  54. Hinding, B.; Deis, N.; Gornostayeva, M.; Götz, C.; Jünger, J. Patient handover—The poor relation of medical training? GMS J. Med. Educ. 2019, 36, Doc19. [Google Scholar] [CrossRef] [PubMed]
  55. Bundesministerium für Gesundheit. Allianz für Gesundheitskompetenz. Available online: https://www.bundesgesundheitsministerium.de/gesundheitskompetenz/allianz-fuer-gesundheitskompetenz.html (accessed on 18 February 2021).
  56. Bundesministerium für Gesundheit. Ziele des Nationalen Krebsplans. Available online: https://www.bundesgesundheitsministerium.de/themen/praevention/nationaler-krebsplan/handlungsfelder/ziele-des-nationalen-krebsplans.html (accessed on 18 February 2021).
  57. Centers for Disease Control and Prevention. Health Literacy. Available online: https://www.cdc.gov/healthliteracy/learn/index.html?ACSTrackingID=USCDC_501-DM39562&ACSTrackingLabel=New%20Definitions%20of%20Health%20Literacy%20Released&deliveryName=USCDC_501-DM39562 (accessed on 18 February 2021).
  58. Bundesanzeiger. Gesetz zur Weiterentwicklung der Krebsfrüherkennung und zur Qualitätssicherung Durch Klinische Krebsregister (Krebsfrüherkennungs- und -registergesetz-KFRG). In Bundesgesetzblatt Jahrgang 2013 Teil I Nr. 16 vom 8.4.2013; Bundesanzeiger Verlag: Köln, Germany, 2013; pp. 617–623. [Google Scholar]
  59. European Colorectal Cancer Screening Guidelines Working Group. European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full supplement publication. Endoscopy 2013, 45, 51–59. [Google Scholar] [CrossRef]
  60. Häder, M. Erhebungsmethoden. In Empirische Sozialforschung. Eine Einführung; Häder, M., Ed.; VS Verlag für Sozialwissenschaften: Wiesbaden, Germany, 2010; pp. 187–337. [Google Scholar]
Table 1. Characteristics of the study population aged 55 years or older.
Table 1. Characteristics of the study population aged 55 years or older.
n (Unweighted) % (Weighted)95% CI
Socio-demographic factors
GenderMale40946.842.8–50.8
Female52753.249.2–57.2
Age55–59 years20626.222.9–29.8
60–64 years20021.818.7–25.3
≥65 years47652.048.0–55.9
Socioeconomic statusLow10620.517.0–24.5
Medium47358.354.3–62.2
High33621.218.7–24.0
Missing21
Health status
Self-perceived
general health
Very good14713.110.8–15.7
Good46447.243.2–51.2
Fair23529.125.5–32.9
Bad758.96.8–11.6
Very bad141.71.0–3.1
Missing1
Long-standing
health problem
Yes46850.346.3–54.3
No46649.754.7–53.7
Missing2
Limitation in activities because of health problemsSeverely limited13016.113.2–19.4
Limited but not severely25731.327.6–35.3
Not Limited54852.648.6–56.6
Missing1
Attitudes and beliefs
Health awareness Not at all182.31.3–3.9
Less strong475.03.6–6.9
Moderate35338.734.9–42.6
Strong37840.836.9–44.8
Very strong14013.310.8–16.2
Health-related
locus of control
Nothing20.20.0–0.7
Little192.51.4–4.5
Some23928.034.5–31.7
Much32534.030.3–37.9
Very much34835.331.6–39.2
Missing3
Treatment decision-making preferences Physician’s decision favoured11014.111.3–17.5
Joint decision-making favoured51654.150.0–58.1
Own decision-making favoured27531.828.1–35.8
Missing35
Counselling
Counselling on CRC and screening optionsYes58260.656.6–64.4
No35339.435.6–43.4
Missing1
Abbreviations: CI: confidence interval, CRC: colorectal cancer.
Table 2. Intention to participate in screening colonoscopy by the examined determinants (relative frequencies expressed as percentages).
Table 2. Intention to participate in screening colonoscopy by the examined determinants (relative frequencies expressed as percentages).
MenWomen
%95% CIp-Value%95% CIp-Value
Total44.338.1–50.6 28.824.2–33.9
Socio-demographic factors
Age
55–59 years68.256.9–77.70.000042.732.3–53.70.0000
60–64 years49.735.7–63.8 39.128.9–50.2
≥ 65 years27.519.9–36.6 18.813.7–25.4
Socioeconomic status
Low42.325.1–61.70.385625.416.0–37.90.0732
Medium48.339.4–57.3 27.121.3–33.7
High37.730.0–46.1 42.233.0–52.0
Health status
Self-perceived general health
Very good/good44.636.9–52.50.907332.226.3–38.60.1113
Fair/bad/very bad43.833.8–54.4 23.816.8–32.5
Long-standing health problem
Yes41.132.4–50.40.296529.322.7–36.90.8853
No47.839.2–56.6 28.622.5–35.6
Limitation in activities
because of health problems
Severely limited/limited but not severely38.129.2–47.90.050724.918.3–32.90.1524
Not limited50.742.6–58.8 32.226.1–39.0
Attitudes and beliefs
Health awareness
Moderate/less strong/not at all43.835.4–52.60.895925.119.0–32.30.1667
Very strong/strong44.635.9–53.8 31.925.4–39.1
Health-related locus of control
Nothing/little/some38.127.0–50.60.217527.119.3–36.50.6049
Much/very much47.139.8–51.1 29.924.4–36.1
Treatment decision-making preferences
Physician’s decision favoured26.214.5–42.60.018233.418.8–52.10.4384
Joint decision making favoured52.244.0–60.3 31.925.4–39.1
Own decision making favoured45.032.5–58.3 25.118.2–33.6
Counselling
Counselling on CRC and screening options
Yes48.840.6–56.20.119940.533.9–47.40.0000
No37.727.7–48.8 10.96.8–17.0
Abbreviations: CI: confidence interval, CRC: colorectal cancer.
Table 3. Odds ratios of intention to participate in screening colonoscopy by the examined determinants.
Table 3. Odds ratios of intention to participate in screening colonoscopy by the examined determinants.
MenWomen
OR (95% CI)p-ValueAdjusted * OR (95% CI)p-ValueOR (95% CI)p-ValueAdjusted * OR (95% CI)p-Value
Age
55–59 years5.68
(2.98–10.80)
0.000- 3.21
(1.79–5.76)
0.000-
60–64 years2.61
(1.28–5.33)
0.008- 2.76
(1.53–5.00)
0.001-
≥65 years1.00 (Ref.) - 1.00 (Ref.) -
Socioeconomic Status
Low1.21
(0.52–2.85)
0.656- 0.47
(0.23–0.94)
0.034-
Medium1.54
(0.94–2.54)
0.087- 0.51
(0.31–0.84)
0.009-
High1.00 (Ref.) - 1.00 (Ref.) -
Treatment decision-making preferences
Physician’s decision
favoured
1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.)
Joint decision making
favoured
3.08
(1.37–6.92)
0.0063.99
(1.58–10.09)
0.0040.93
(0.40–2.15)
0.8720.77
(0.33–1.82)
0.551
Own decision making
favoured
2.31
(0.93–5.74)
0.0712.73
(0.94–7.91)
0.0640.67
(0.28–1.61)
0.3690.63
(0.26–1.54)
0.307
Counselling on CRC and screening options
No1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.) 1.00 (Ref.)
Yes1.55
(0.89–2.69)
0.1201.42
(0.77–2.62)
0.2615.56
(3.10–10.03)
0.0005.92
(3.20–10.95)
0.000
* Adjusted for age and socioeconomic status; Abbreviations: CI: confidence interval, CRC: colorectal cancer, OR: odds ratio, Ref.: reference category.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Starker, A.; Prütz, F.; Jordan, S. Intention for Screening Colonoscopy among Previous Non-Participants: Results of a Representative Cross-Sectional Study in Germany. Int. J. Environ. Res. Public Health 2021, 18, 4160. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18084160

AMA Style

Starker A, Prütz F, Jordan S. Intention for Screening Colonoscopy among Previous Non-Participants: Results of a Representative Cross-Sectional Study in Germany. International Journal of Environmental Research and Public Health. 2021; 18(8):4160. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18084160

Chicago/Turabian Style

Starker, Anne, Franziska Prütz, and Susanne Jordan. 2021. "Intention for Screening Colonoscopy among Previous Non-Participants: Results of a Representative Cross-Sectional Study in Germany" International Journal of Environmental Research and Public Health 18, no. 8: 4160. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18084160

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop